These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38902187)

  • 1. Strategic vaccine stockpiles for regional epidemics of emerging viruses: A geospatial modeling framework.
    Carlson CJ; Garnier R; Tiu A; Luby SP; Bansal S
    Vaccine; 2024 Oct; 42(23):126051. PubMed ID: 38902187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Projecting vaccine demand and impact for emerging zoonotic pathogens.
    Lerch A; Ten Bosch QA; L'Azou Jackson M; Bettis AA; Bernuzzi M; Murphy GAV; Tran QM; Huber JH; Siraj AS; Bron GM; Elliott M; Hartlage CS; Koh S; Strimbu K; Walters M; Perkins TA; Moore SM
    BMC Med; 2022 Jun; 20(1):202. PubMed ID: 35705986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What is new in infectious diseases: Nipah virus, MERS-CoV and the Blueprint List of the World Health Organization.
    Rizzardini G; Saporito T; Visconti A
    Infez Med; 2018 Sep; 26(3):195-198. PubMed ID: 30246760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MERS coronavirus outbreak: Implications for emerging viral infections.
    Al-Omari A; Rabaan AA; Salih S; Al-Tawfiq JA; Memish ZA
    Diagn Microbiol Infect Dis; 2019 Mar; 93(3):265-285. PubMed ID: 30413355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infectious diseases epidemic threats and mass gatherings: refocusing global attention on the continuing spread of the Middle East Respiratory syndrome coronavirus (MERS-CoV).
    Zumla A; Alagaili AN; Cotten M; Azhar EI
    BMC Med; 2016 Sep; 14(1):132. PubMed ID: 27604081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in diagnostics, vaccines and therapeutics for Nipah virus.
    Thakur N; Bailey D
    Microbes Infect; 2019; 21(7):278-286. PubMed ID: 30817995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging infectious diseases. Nipah virus (or a cousin) strikes again.
    Enserink M
    Science; 2004 Feb; 303(5661):1121. PubMed ID: 14976284
    [No Abstract]   [Full Text] [Related]  

  • 8. CEPI: Driving Progress Toward Epidemic Preparedness and Response.
    Gouglas D; Christodoulou M; Plotkin SA; Hatchett R
    Epidemiol Rev; 2019 Jan; 41(1):28-33. PubMed ID: 31673694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccines for emerging infectious diseases: Lessons from MERS coronavirus and Zika virus.
    Maslow JN
    Hum Vaccin Immunother; 2017 Dec; 13(12):2918-2930. PubMed ID: 28846484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccines to Emerging Viruses: Nipah and Hendra.
    Amaya M; Broder CC
    Annu Rev Virol; 2020 Sep; 7(1):447-473. PubMed ID: 32991264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing preparation for large Nipah outbreaks beyond Bangladesh: Preventing a tragedy like Ebola in West Africa.
    Donaldson H; Lucey D
    Int J Infect Dis; 2018 Jul; 72():69-72. PubMed ID: 29879523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccine development for emerging virulent infectious diseases.
    Maslow JN
    Vaccine; 2017 Oct; 35(41):5437-5443. PubMed ID: 28216184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-dose live-attenuated vesicular stomatitis virus-based vaccine protects African green monkeys from Nipah virus disease.
    Prescott J; DeBuysscher BL; Feldmann F; Gardner DJ; Haddock E; Martellaro C; Scott D; Feldmann H
    Vaccine; 2015 Jun; 33(24):2823-9. PubMed ID: 25865472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of proactive and reactive vaccination strategies for health-care workers against MERS-CoV: a mathematical modelling study.
    Laydon DJ; Cauchemez S; Hinsley WR; Bhatt S; Ferguson NM
    Lancet Glob Health; 2023 May; 11(5):e759-e769. PubMed ID: 37061313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nipah virus: a narrative review of viral characteristics and epidemiological determinants.
    Sayed A; Bottu A; Qaisar M; Mane MP; Acharya Y
    Public Health; 2019 Aug; 173():97-104. PubMed ID: 31261032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid development of vaccines against emerging pathogens: The replication-deficient simian adenovirus platform technology.
    Gilbert SC; Warimwe GM
    Vaccine; 2017 Aug; 35(35 Pt A):4461-4464. PubMed ID: 28576573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the potential impact of targeted vaccination strategies against severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) outbreaks in the healthcare setting.
    Abdirizak F; Lewis R; Chowell G
    Theor Biol Med Model; 2019 Oct; 16(1):16. PubMed ID: 31587665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nipah virus infection: A review.
    Aditi ; Shariff M
    Epidemiol Infect; 2019 Jan; 147():e95. PubMed ID: 30869046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virology. A henipavirus vaccine in sight.
    von Messling V; Cattaneo R
    Science; 2012 Aug; 337(6095):651-2. PubMed ID: 22879489
    [No Abstract]   [Full Text] [Related]  

  • 20. Enhanced surveillance and response approaches for pilgrims and local Saudi populations against emerging Nipah, Zika and Ebola viral diseases outbreaks threats.
    Tambo E; El-Dessouky AG; Khater EIM; Xianonng Z
    J Infect Public Health; 2020 May; 13(5):674-678. PubMed ID: 32265162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.